Neuroendocrine tumors: Peptide receptors radionuclide therapy (PRRT)

被引：0
作者：
Otte, Andreas [1 ]
机构：
[1] Offenburg Univ, Dept Elect Engn & Informat Technol, Div Biomed Engn, Badstr 24, D-77652 Offenburg, Germany
来源：
HELLENIC JOURNAL OF NUCLEAR MEDICINE | 2016年 / 19卷 / 02期
关键词：
SOMATOSTATIN-ANALOG; DOTATOC;
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：182 / 182
页数：1
相关论文
共 5 条
[1]  
Merlo A, 1999, CLIN CANCER RES, V5, P1025
[2]   Yttrium-90-labelled somatostatin-analogue for cancer treatment [J].
Otte, A ;
Mueller-Brand, J ;
Dellas, S ;
Nitzsche, EU ;
Herrmann, R ;
Maecke, HR .
LANCET, 1998, 351 (9100) :417-418
[3]  
Otte A, 1997, EUR J NUCL MED, V24, P792
[4]   Practical and clinical benefits of radioimmunotherapy lead to advantages in cost-effectiveness in the treatment of patients with non-Hodgkin's lymphoma [J].
Otte, Andreas ;
Thompson, Sally L. .
NUCLEAR MEDICINE COMMUNICATIONS, 2006, 27 (10) :753-756
[5]  
Papamichail DG, 2016, HELL J NUCL MED, V19, P75
1